Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

7,313 total articles

Gold.com COO Disposes of 10,000 Shares, Exercises 10,000 Options

Gold.com COO Disposes of 10,000 Shares, Exercises 10,000 Options

Gold.com, Inc. (NASDAQ:GOLD) Chief Operating Officer Brian Aquilino sold 10,000 shares on February 11, 2026, and concurrently exercised options for 10,000 additional shares. The transactions occurred as the stock trades near its 52-week high after a 104% year-over-year gain, while the company pursues share repurchases and completed a $150 million p…

Horizon Kinetics Adds One Share to Its Texas Pacific Land Stake; Company Advances Data Center Tie-Up and Stock Split Plans

Horizon Kinetics Adds One Share to Its Texas Pacific Land Stake; Company Advances Data Center Tie-Up and Stock Split Plans

Horizon Kinetics Asset Management LLC, a reported ten percent holder of Texas Pacific Land Corp (NYSE: TPL), disclosed the purchase of a single common share on February 12, 2026, for $413.24. The transaction leaves the firm with 3,479,372 directly held shares. Separately, Texas Pacific Land announced a partnership with Bolt Data & Energy to develop…

Renn Fund President Purchases $3,095 in RCG Shares

Renn Fund President Purchases $3,095 in RCG Shares

Murray Stahl, President and Co-Portfolio Manager at RENN Fund, Inc. (RCG), bought 1,134 shares of RCG common stock on February 12, 2026, in several transactions at $2.73 per share. The purchases totaled $3,095 and increase Stahl's direct stake to 147,734 shares. InvestingPro data shows the stock trading at $2.75, close to its 52-week high, while co…

Apellis Executive Sells $8,152 in Stock to Cover RSU Taxes; Analysts Update Targets After Q4 Pre-Announcement

Apellis Executive Sells $8,152 in Stock to Cover RSU Taxes; Analysts Update Targets After Q4 Pre-Announcement

Apellis Pharmaceuticals executive Mark Jeffrey DeLong sold 368 shares of company stock on February 11, 2026, for $8,152 to cover tax withholding tied to restricted stock units released the prior day. The transaction leaves DeLong with 114,591 directly held shares. The sale coincides with a corporate pre-announcement of $689 million in fourth-quarte…